| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/29/2010 | US20100104537 Methods of treating Parkinson's disease using viral vectors |
| 04/29/2010 | US20100104514 Nanoparticle clusters and methods for forming same |
| 04/29/2010 | DE4035442B4 Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure A medicament comprising as an active ingredient R-α-lipoic acid |
| 04/29/2010 | DE19823940B4 Enterische Fluoxetinpellets Enteric Fluoxetinpellets |
| 04/29/2010 | DE10085492B4 Antimonocytenaktivität von extrakten von Betelpfefferblättern Antimonocytenaktivität of extracts of Betelpfefferblättern |
| 04/29/2010 | CA2741415A1 Swellable biodegradable polymeric matrices and methods |
| 04/29/2010 | CA2740476A1 Stable tablet containing 4,5-epoxymorphinan derivative |
| 04/29/2010 | CA2740001A1 Urea-based film-forming solution for treating nail psoriasis |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 04/28/2010 | EP2180027A1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel |
| 04/28/2010 | EP2179728A1 Non-gelatin shell material of hard capsule and process for preparing thereof |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178919A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178918A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178565A1 Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 04/28/2010 | EP2178564A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 04/28/2010 | EP2178528A1 Stabilized tolterodine tartrate formulations |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/28/2010 | EP2178521A1 Stable medicated chewing gum comprising cyclodextrin inclusion complex |
| 04/28/2010 | EP2178518A2 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
| 04/28/2010 | EP2178509A2 Nucleic acid-lipopolymer compositions |
| 04/28/2010 | EP2178504A2 Preservative-free prostaglandin-based ophthalmic solution |
| 04/28/2010 | EP1729811B1 Cream-gel containing ivermectin |
| 04/28/2010 | EP1599228B1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 04/28/2010 | EP1581615B1 Peptide conjugated anti-cancer prodrugs |
| 04/28/2010 | EP1569663B1 Ifosfamide compositions for parenteral administration and a process for their preparation |
| 04/28/2010 | EP1480650B1 Novel crystalline forms of the anti-cancer compound zd1839 |
| 04/28/2010 | EP1480615B1 Formoterol superfine formulation |
| 04/28/2010 | EP1437380B1 Polymeric hydrogel |
| 04/28/2010 | EP0831858B1 Intrauterine chemical necrosing method and composition |
| 04/28/2010 | CN1902352B Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 04/28/2010 | CN1809376B Liquid stabilized protein formulations in coated pharmaceutical containers |
| 04/28/2010 | CN1777419B Pharmaceutical compositions of CETP inhibitors |
| 04/28/2010 | CN1761485B Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 04/28/2010 | CN1756559B Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant |
| 04/28/2010 | CN1753968B Antioxidative composition and composition for external use |
| 04/28/2010 | CN1717252B Preparation containing basic drug |
| 04/28/2010 | CN1705683B Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 04/28/2010 | CN1703199B Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug |
| 04/28/2010 | CN1691965B Pharmaceutical composition for controlled release and manufacturing method thereof |
| 04/28/2010 | CN1679959B Liver targeted auxiliary material containing D-glactose and sterol and its use |
| 04/28/2010 | CN1678295B Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility |
| 04/28/2010 | CN1662260B Process for producing sustained-release composition |
| 04/28/2010 | CN1620284B Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tool for producing it |
| 04/28/2010 | CN1620257B Matrix-forming composition containing pectin |
| 04/28/2010 | CN1525852B Granules and granules coated with a masked taste |
| 04/28/2010 | CN1444948B Liposome of Breviscapine and its preparing method |
| 04/28/2010 | CN1438838B Confectionery product comprising functional ingredient |
| 04/28/2010 | CN1416335B New self emulsifying drug delivery system |
| 04/28/2010 | CN101698692A Waist crosslinked amphiphilic nano micelle and preparation method thereof |
| 04/28/2010 | CN101698685A Alginic acid ester nanoparticles, preparation method and application thereof |
| 04/28/2010 | CN101698104A Method for nucleus-shell turning of waist crosslinked amphiphilic nano micelle |
| 04/28/2010 | CN101698101A Medicine composite for treating vaginitis |
| 04/28/2010 | CN101698098A Preparation method of sustained release preparation of phytohemagglutinin |
| 04/28/2010 | CN101698095A Drug composition liniment or lotion for treating white vein diseases and preparation method thereof |
| 04/28/2010 | CN101698089A Traditional Chinese medicine volatile oil clathrate compound and preparation method thereof |
| 04/28/2010 | CN101698071A Anticancer capsule |
| 04/28/2010 | CN101697988A Taste hiding composition and application thereof in Xuesaitong chewable tablet |
| 04/28/2010 | CN101697978A Asparagus powder and chewable tablet as well as manufacturing method thereof |
| 04/28/2010 | CN101697975A GSLS tablets used for animals and poultries and preparation method thereof |
| 04/28/2010 | CN101697974A GSLS capsules used for animals and poultries and preparation method thereof |
| 04/28/2010 | CN101697973A Cefathiamidine preparation for injection and preparation method thereof |
| 04/28/2010 | CN101697969A Ornidazole medicinal composition and preparation method thereof |
| 04/28/2010 | CN101697965A Inhalation capsules |
| 04/28/2010 | CN101697964A Combretaftation A-4P frozen preparation and preparation method thereof |
| 04/28/2010 | CN101697963A Method for preparing PLGA slow-release microsphere carrying docetaxel and application thereof in chemotherapy of mesenchyma stroma of tumors under ultrasonic mediation |
| 04/28/2010 | CN101697962A Process for preparing matrine-loaded magnetic chitosan microspheres |
| 04/28/2010 | CN101697961A New cefmenoxime hydrochloride preparation for drug administration by injection and preparation method thereof |
| 04/28/2010 | CN101697959A Potassium sodium dehydroandrographolide succinate and sodium chloride injection and preparation method thereof |
| 04/27/2010 | US7705045 compounds comprising a specifier linked to two or more of the same or different leaving groups via a self-eliminating multiple release spacer or spacer system, which compounds upon a single activation step, in particular removal or transformation of the specifier, release two or more leaving groups |
| 04/27/2010 | US7704987 Metal complex based on 1,10-phenanthroline binds to histidine of the N-terminal loop of the peptide in such a way that the N-terminal loop (amino acid residues 1-15) is blocked or destabilised to inhibit the binding copper, zinc and iron compounds -ones of magnesium /calcium; Alzheimer,s disease |
| 04/27/2010 | US7704975 Modafinil compound and cyclodextrin mixtures |
| 04/27/2010 | US7704969 Transfection complexes |
| 04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
| 04/27/2010 | US7704964 Methods and compounds for the targeting of protein to exosomes |
| 04/27/2010 | US7704954 Method and carrier complexes for delivering molecules to cells |
| 04/27/2010 | US7704534 Continuous process for production of oil seed protein isolate |
| 04/27/2010 | US7704526 Sustained release composition for oral administration of drugs |
| 04/27/2010 | US7704525 Lipid microparticles by cryogenic micronization |
| 04/27/2010 | US7704524 Transdermal botulinum toxin administration for the treatment of spastic muscle pain |
| 04/27/2010 | US7704523 Microbial cellulose wound dressing for treating chronic wounds |
| 04/27/2010 | US7704518 Foamable vehicle and pharmaceutical compositions thereof |
| 04/27/2010 | US7704516 Administration be done percutaneously (topically), to avoid the first-pass effect and related liver metabolism of the 4-hydroxy tamoxifen; side effect reduction |
| 04/27/2010 | US7704514 Vaccines |
| 04/27/2010 | US7704512 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/27/2010 | US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | CA2486571C Pharmaceutical composition |
| 04/27/2010 | CA2476494C Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 04/27/2010 | CA2461354C Fondant-based pharmaceutical composition |
| 04/27/2010 | CA2438692C Injectable water-in-oil emulsions |
| 04/27/2010 | CA2350246C Controlled delivery of active agents |
| 04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
| 04/27/2010 | CA2323102C Monolithic tablet for controlled drug release |
| 04/27/2010 | CA2297998C Aqueous solution for use in the treatment of degenerative or autoimmune diseases and as an immunomodulatory agent |
| 04/27/2010 | CA2278626C Novel method for the isolation of polysaccharides |
| 04/22/2010 | WO2010045568A1 Modified blood factors comprising a low degree of water soluble polymer |
| 04/22/2010 | WO2010045506A2 Sustained drug delivery system |
| 04/22/2010 | WO2010045431A2 Dry powder formulations, vaccines and methods |